Refine
Year of publication
Document Type
- Article (18) (remove)
Has Fulltext
- yes (18)
Is part of the Bibliography
- no (18)
Keywords
- EGFR (1)
- EMD 55900 (1)
- EMD 72000 (1)
- HER2 (1)
- HER2/neu (1)
- Metastatic breast cancer (1)
- RNA interference (1)
- Trastuzumab (1)
- antibody (1)
- antiproliferative activity (1)
Institute
- Medizin (16)
- Georg-Speyer-Haus (3)
- Geowissenschaften (2)
In eukaryotes, double-stranded (ds) RNA induces sequence-specific inhibition of gene expression referred to as RNA interference (RNAi). We exploited RNAi to define the role of HER2/neu in the neoplastic proliferation of human breast cancer cells. We transfected SK-BR-3, BT-474, MCF-7, and MDA-MB-468 breast cancer cells with short interfering RNA (siRNA) targeted against human HER2/neu and analyzed the specific inhibition of HER2/neu expression by Northern and Western blots. Transfection with HER2/neu-specific siRNA resulted in a sequence-specific decrease in HER2/neu mRNA and protein levels. Moreover, transfection with HER2/neu siRNA caused cell cycle arrest at G0/G1 in the breast cancer cell lines SKBR-3 and BT-474, consistent with a powerful RNA silencing effect. siRNA treatment resulted in an antiproliferative and apoptotic response in cells overexpressing HER2/neu, but had no influence in cells with almost no expression of HER2/neu proteins like MDA-MB-468 cells. These data indicate that HER2/neu function is essential for the proliferation of HER2/neuoverexpressing breast cancer cells. Our observations suggest that siRNA targeted against human HER2/neu may be valuable tools as anti proliferative agents that display activity against neoplastic cells at very low doses.